Deltybatm 50 mg FC tablets

Indication

Treatment of pulmonary multi-drug-resistant tuberculosis (MDR-TB).

Dosage (summary)

Adults: 100 mg twice daily for 24 weeks; Children 30-50 kg: 50 mg twice daily.

Special Populations

• Elderly patients (> 65 years)
• Renal impairment
• Hepatic impairment

Pregnancy & Breastfeeding

Not recommended in pregnancy; unknown if excreted in breast milk.

Key Drug Interactions

• Strong CYP3A4 inducers (e.g., carbamazepine)
• QT prolonging medications

Contraindications

• Hypersensitivity to delamanid
• Severe hepatic impairment
• Cardiac failure
• Uncontrolled dysrhythmias
• QT prolongation

Common side effects

• Nausea
• Vomiting
• Headache
• Insomnia
• Dizziness

Counselling Points

• Take with food
• Avoid in pregnancy
• Monitor for cardiac symptoms